BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 12787536)

  • 21. Inherited thrombophilia and fetal loss.
    Brenner B
    Curr Opin Hematol; 2000 Sep; 7(5):290-5. PubMed ID: 10961579
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Impact of Inherited Thrombophilia Types and Low Molecular Weight Heparin Treatment on Pregnancy Complications in Women with Previous Adverse Outcome.
    Aracic N; Roje D; Jakus IA; Bakotin M; Stefanovic V
    Yonsei Med J; 2016 Sep; 57(5):1230-5. PubMed ID: 27401656
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Successful pregnancy outcome in women with bad obstetric history and recurrent fetal loss due to thrombophilia: effect of unfractionated heparin and low-molecular weight heparin.
    Ghosh K; Shetty S; Vora S; Salvi V
    Clin Appl Thromb Hemost; 2008 Apr; 14(2):174-9. PubMed ID: 18160603
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Does low-molecular-weight heparin influence fetal growth or uterine and umbilical arterial Doppler in women with a history of early-onset uteroplacental insufficiency and an inheritable thrombophilia? Secondary randomised controlled trial results.
    Abheiden C; Van Hoorn ME; Hague WM; Kostense PJ; van Pampus MG; de Vries J
    BJOG; 2016 Apr; 123(5):797-805. PubMed ID: 26036190
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of 2 approaches in management of pregnant women with inherited trombophilias: Prospective analytical cohort study.
    Dugalic S; Petronijevic M; Stefanovic A; Stefanovic K; Petronijevic SV; Stanisavljevic D; Kepeci SP; Milincic N; Pantic I; Perovic M
    Medicine (Baltimore); 2019 Aug; 98(34):e16883. PubMed ID: 31441864
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inherited thrombophilia and pregnancy complications revisited.
    Rodger MA; Paidas M; McLintock C; Middeldorp S; Kahn S; Martinelli I; Hague W; Rosene Montella K; Greer I
    Obstet Gynecol; 2008 Aug; 112(2 Pt 1):320-4. PubMed ID: 18669729
    [TBL] [Abstract][Full Text] [Related]  

  • 27. THE ROLE OF LOW MOLECULAR WEIGHT HEPARIN IN WOMEN WITH HEREDITARY THROMBOPHILIA FOR GOOD PERINATAL OUTCOME.
    Sokol V; Ivanišević M; Herman M; Đelmiš J
    Acta Clin Croat; 2016 Jun; 55(2):309-15. PubMed ID: 28394549
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High frequency of congenital thrombophilia in women with pathological pregnancies?
    Rasmussen A; Ravn P
    Acta Obstet Gynecol Scand; 2004 Sep; 83(9):808-17. PubMed ID: 15315591
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thromboprophylaxis implementation during pregnancy in women with recurrent foetal losses and thrombophilia.
    Mitić G; Novakov Mikić A; Povazan L; Mitreski A; Kopitović V; Vejnović T
    Med Pregl; 2011; 64(9-10):471-5. PubMed ID: 22097113
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aspirin, low molecular weight heparin, or both in preventing pregnancy complications in women with recurrent pregnancy loss and factor V Leiden mutation.
    Karadağ C; Akar B; Gönenç G; Aslancan R; Yılmaz N; Çalışkan E
    J Matern Fetal Neonatal Med; 2020 Jun; 33(11):1934-1939. PubMed ID: 31550962
    [No Abstract]   [Full Text] [Related]  

  • 31. Placental pathology in fetal thrombophilia.
    Ariel I; Anteby E; Hamani Y; Redline RW
    Hum Pathol; 2004 Jun; 35(6):729-33. PubMed ID: 15188139
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anticoagulant prophylaxis for placenta mediated pregnancy complications.
    Rodger MA
    Thromb Res; 2011 Feb; 127 Suppl 3():S76-80. PubMed ID: 21262448
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Outcomes in an obstetrical population with hereditary thrombophilia and high tobacco use.
    Calhoun B; Hoover E; Seybold D; Broce M; Hill A; Schaible B; Bracero LA
    J Matern Fetal Neonatal Med; 2018 May; 31(10):1267-1271. PubMed ID: 28367651
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thrombophilia and pregnancy complications.
    Brenner B; Grabowski EF; Hellgren M; Kenet G; Massicotte P; Manco-Johnson M; Mathew P; Muntean W; Schlegel N; Nowak-Göttl U
    Thromb Haemost; 2004 Oct; 92(4):678-81. PubMed ID: 15467895
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro evidences of heparin's effects on embryo implantation and trophoblast development.
    Tersigni C; Marana R; Santamarìa A; Castellani R; Scambia G; Simone ND
    Reprod Sci; 2012 May; 19(5):454-62. PubMed ID: 22378860
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Low-molecular-weight heparin combined with aspirin in pregnant women with thrombophilia and a history of preeclampsia or fetal growth restriction: a preliminary study.
    Riyazi N; Leeda M; de Vries JI; Huijgens PC; van Geijn HP; Dekker GA
    Eur J Obstet Gynecol Reprod Biol; 1998 Sep; 80(1):49-54. PubMed ID: 9758259
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antithrombotic therapy for pregnancy loss.
    de Jong PG; Goddijn M; Middeldorp S
    Hum Reprod Update; 2013; 19(6):656-73. PubMed ID: 23766357
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gestational outcome in thrombophilic women with recurrent pregnancy loss treated by enoxaparin.
    Brenner B; Hoffman R; Blumenfeld Z; Weiner Z; Younis JS
    Thromb Haemost; 2000 May; 83(5):693-7. PubMed ID: 10823264
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Do placental lesions reflect thrombophilia state in women with adverse pregnancy outcome?
    Mousa HA; Alfirevic1 Z
    Hum Reprod; 2000 Aug; 15(8):1830-3. PubMed ID: 10920112
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of adverse perinatal outcome in inherited thrombophilias: a clinical study.
    Kosar A; Kasapoglu B; Kalyoncu S; Turan H; Balcik OS; Gümüs EI
    Blood Coagul Fibrinolysis; 2011 Jan; 22(1):14-8. PubMed ID: 21042205
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.